Ozempic may be reshaping the brain, scientists say
Ozempic was supposed to be a gut story. Then Allison Shapiro looked at the brain scans. An assistant…
ETFs in Focus on Eli Lilly’s Solid Q2 Earnings, Weak Obesity Data
Eli Lilly and Company LLY reported robust second-quarter 2025 results, wherein it beat estimates on both the top…